Dr. Manasanch is an Associate Professor, tenure-track, at the Department of Lymphoma/Myeloma at the University of Texas M.D. Anderson Cancer Center where she focuses on the research and treatment of plasma cell dyscrasias. She leads the Early Myeloma Program and co-directs the Myeloma Tissue Bank at MD Anderson with a focus in understanding the mechanisms of progression through new technology, finding new therapeutics and applying immunotherapy to early treatment.